Rotateq vaccine 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FY759
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,681
Award facts
- Contract value 100% obligated
- $10,681.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $10,681.06 delivery order to Amerisourcebergen Drug Corp on May 6, 2026, for Rotateq vaccine (2 mL), with ultimate completion on May 7, 2026.
Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside applied. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., and operates as a pharmaceutical distributor and medical supplier for the Department of Defense and federal healthcare systems, competing on full-and-open competitive awards without set-asides.
Quick answers
Who was awarded contract SPE2DR26FY759?
SPE2DR26FY759 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 6, 2026.
How much is contract SPE2DR26FY759 worth?
The government has obligated $10,681 on SPE2DR26FY759.
Is contract SPE2DR26FY759 an order under another contract?
Yes. SPE2DR26FY759 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FY759 competed?
The extent of competition for SPE2DR26FY759 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award